About the Fund​

The Department of Ophthalmology and Visual Sciences (OVS) and the Centre for Regenerative Medicine and Stem Cell Research (CRM) at Aga Khan University (AKU) are dedicated to improving patient care through groundbreaking research.


Building on its strong expertise in glaucoma and retinal disease, AKU is launching the Innovation in Eye Research Fund, with the goal of developing and testing new, breakthrough solutions to the leading causes of blindness. 

​​Join the cause and make a lasting impact

​Why support this fund?

​"In partnership with the Centre for Regenerative Medicine and the Clinical Trials Unit, we are collaborating to find breakthrough therapies for major causes of vision loss in Pakistan and beyond, including developing innovative therapies for various types of glaucoma and inherited retinal disease. ​Your support can accelerate our efforts to develop innovative solutions for restoring sight."


Dr Karim F. Damji
Professor and Chair
Department of Ophthalmology and Visual Sciences, AKU​